.Bristol Myers Squibb has actually had a whiplash change of mind on its BCMA bispecific T-cell engag...
.Charles Baum, M.D., Ph.D., that managed Mirati Therapeutics' $ 5.8 billion sale to Bristol Myers Sq...
.After communicating to much more than 200 firms to partner a Tourette syndrome treatment that showe...
.Novartis has possessed some rotten luck with bispecific antitoxins in the past, but evaluating by t...
.Pinetree Rehabs are going to help AstraZeneca plant some trees in its pipeline along with a brand n...
.GRO Biosciences has ended the full week along with an additional $60.3 million in the banking compa...
.Welcome to this week's Chutes & Ladders, our roundup of notable leadership hirings, firings and ...